| Q34206939 | A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies |
| Q34207045 | A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors |
| Q34396506 | ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS |
| Q41224419 | Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies |
| Q28659287 | Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation |
| Q42580245 | Biopsy findings in liver transplant patients. |
| Q41898254 | Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms |
| Q35841030 | Detection of small hepatocellular carcinomas in cirrhotic livers using iodised oil computed tomography |
| Q34236993 | Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy |
| Q42574211 | Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury |
| Q34207259 | Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease |
| Q34256643 | Hepatitis viral markers in patients undergoing primary liver transplants |
| Q34206976 | Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? |
| Q42092931 | Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection? |
| Q34275845 | Multivisceral intestinal transplantation: surgical pathology |
| Q34312217 | Pathologic analysis of liver transplantation for primary biliary cirrhosis |
| Q37249647 | Portal lymphadenopathy associated with lipofuscin in chronic cholestatic liver disease |
| Q72747680 | The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation |
| Q38607072 | The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? |
| Q40881579 | Types, causes, and therapies of hepatitis occurring in liver transplant recipients |
| Q34858557 | Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients |